Investors
Corporate Profile
At Bellerophon Therapeutics, we aim to transform the lives of people suffering from cardiopulmonary diseases by developing innovative therapies at the intersection of drugs and devices for these therapeutic areas and to do so while serving the best interests of our shareholders.
We are currently developing three product candidates under our INOpulse pro... more >
Recent News
Stock Quote
Copyright West LLC. Minimum 15 minutes delayed.
Upcoming Events
-
Thursday, June 20, 2019 11:00 am EDT
Bellerophon Therapeutics Inc. at the JMP Securities Life Sciences ConferenceDescription Click Here for more JMP Conference information
Add to Calender
Presentations
-
Corporate Presentation
Corporate Presentation 1.5 MB -
KOL Day Presentation
KOL Day Presentation 4 MB -
ATS 2019 PH-ILD Poster
ATS 2019 PH-ILD Poster 310.5 KB -
2019 ATS PH-ILD Presentation
2019 ATS PH-ILD Presentation 452.8 KB -
2019 PVRI Poster – Actigraphy in PH-PF
-
2019 PVRI Poster – iNO DDI Study
2019 PVRI Poster – iNO DDI Study 339.9 KB -
Key Opinion Leader Lunch : Pulmonary Hypertension Associated with Interstitial Lung Disease (ILD) with Dr. Steve Nathan
-
2017 ATS Poster - PH-IPF
2017 ATS Poster - PH-IPF 2.2 MB -
2017 ATS Poster - PH-COPD
-
2017 ISHLT Poster
2017 ISHLT Poster 417.9 KB -
2016 ATS Poster
2016 ATS Poster 971 KB -
2015 PHPN Poster
2015 PHPN Poster 684.5 KB
Copyright West LLC. Minimum 15 minutes delayed.